Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).
https://gardp.org/this-is-big/
https://gardp.org/this-is-big/
Pinned
⏰ Don’t miss your chance to present at #ACC2026!
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Reposted by Global Antibiotic R&D Partnership (GARDP)
Antimicrobial resistance (AMR) is a growing global health crisis. Presenters and participants discuss the complexities of AMR and explore innovative approaches and story ideas to enhance meaningful media coverage.
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
November 10, 2025 at 8:16 AM
Antimicrobial resistance (AMR) is a growing global health crisis. Presenters and participants discuss the complexities of AMR and explore innovative approaches and story ideas to enhance meaningful media coverage.
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
War is pushing us to a drug resistance tipping point.
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
War is pushing us to a drug resistance tipping point
Failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere
www.ft.com
November 6, 2025 at 4:34 PM
War is pushing us to a drug resistance tipping point.
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
📢 10 days left to submit abstracts for #ACC2026!
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
November 5, 2025 at 7:06 AM
We’re excited to share that 1,052 people joined our latest #REVIVE webinar — our biggest yet!🎉
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
November 2, 2025 at 7:00 AM
We’re excited to share that 1,052 people joined our latest #REVIVE webinar — our biggest yet!🎉
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Our DER team has been out at key scientific forums this year, presenting work in early antibiotic discovery.
Take a look at their posters👇
Take a look at their posters👇
October 31, 2025 at 8:36 AM
Our DER team has been out at key scientific forums this year, presenting work in early antibiotic discovery.
Take a look at their posters👇
Take a look at their posters👇
🌍 The ComBac-Africa website is now live!
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
ComBac-Africa | Fighting AMR in Sub-Saharan Africa
Advancing diagnostics and antimicrobial stewardship in Africa to combat drug-resistant bacteria and improve treatment access.
www.combac-africa.org
October 30, 2025 at 6:53 AM
🌍 The ComBac-Africa website is now live!
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
⏰ Don’t miss your chance to present at #ACC2026!
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
October 28, 2025 at 12:12 PM
⏰ Don’t miss your chance to present at #ACC2026!
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
🔴 Live TODAY!
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
October 28, 2025 at 6:00 AM
🔴 Live TODAY!
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
📢 Last chance to register!
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
October 27, 2025 at 6:58 AM
📢 Last chance to register!
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
🗓️ 2 days to go!
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
October 26, 2025 at 3:34 AM
🗓️ 2 days to go!
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
October 23, 2025 at 6:06 AM
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
📊 The @who.int #GLASSReport 2025 shows rising resistance, especially among Gram-negative pathogens.
At the launch, Dr. Jennifer Cohn said the data shows progress and urgency. Stronger surveillance, smarter antibiotic use and R&D are key to stay ahead of #AMR.
🎥 www.youtube.com/watch?v=GqRC...
At the launch, Dr. Jennifer Cohn said the data shows progress and urgency. Stronger surveillance, smarter antibiotic use and R&D are key to stay ahead of #AMR.
🎥 www.youtube.com/watch?v=GqRC...
WHO AMR|13th October 2025 | English
YouTube video by ECHO India
www.youtube.com
October 22, 2025 at 10:35 AM
📊 The @who.int #GLASSReport 2025 shows rising resistance, especially among Gram-negative pathogens.
At the launch, Dr. Jennifer Cohn said the data shows progress and urgency. Stronger surveillance, smarter antibiotic use and R&D are key to stay ahead of #AMR.
🎥 www.youtube.com/watch?v=GqRC...
At the launch, Dr. Jennifer Cohn said the data shows progress and urgency. Stronger surveillance, smarter antibiotic use and R&D are key to stay ahead of #AMR.
🎥 www.youtube.com/watch?v=GqRC...
📢 Exciting news!
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
October 20, 2025 at 8:22 AM
📢 Exciting news!
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Thank you for attending #BioJapan 2025
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
October 16, 2025 at 8:12 AM
Thank you for attending #BioJapan 2025
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
⏳ One month to go!
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
October 16, 2025 at 6:11 AM
⏳ One month to go!
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050.
We need innovation and access to the right antibiotics. 🌍
🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...
We need innovation and access to the right antibiotics. 🌍
🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...
‘As new infections outpace new drugs, are we sleepwalking into a global health disaster?’ | Dr Manica Balasegaram
Much of the political momentum around the antimicrobial resistance crisis has dissipated, but a new report shows the danger to our health has not
www.theguardian.com
October 14, 2025 at 12:15 PM
📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050.
We need innovation and access to the right antibiotics. 🌍
🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...
We need innovation and access to the right antibiotics. 🌍
🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...
🌍 At #WHS2025, GARDP’s Peter Beyer highlighted the impact of tech transfers in a #GSK session.
"Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."
"Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."
October 14, 2025 at 6:32 AM
🚨 @who.int reports a sharp global rise in antibiotic-resistant infections in hospitals.
"Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram
@iansample.bsky.social for @theguardian.com
www.theguardian.com/world/2025/o...
"Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram
@iansample.bsky.social for @theguardian.com
www.theguardian.com/world/2025/o...
Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds
Experts describe findings as deeply concerning and predict 70% increase in related deaths by 2050
www.theguardian.com
October 13, 2025 at 10:32 AM
🚨 @who.int reports a sharp global rise in antibiotic-resistant infections in hospitals.
"Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram
@iansample.bsky.social for @theguardian.com
www.theguardian.com/world/2025/o...
"Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram
@iansample.bsky.social for @theguardian.com
www.theguardian.com/world/2025/o...
Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide.
👉 Submit your nomination: penta-id.org/bfa
👉 Submit your nomination: penta-id.org/bfa
October 13, 2025 at 6:52 AM
Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide.
👉 Submit your nomination: penta-id.org/bfa
👉 Submit your nomination: penta-id.org/bfa
We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
October 13, 2025 at 4:38 AM
We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
When asked what GARDP expects from Japan in the fight against #AMR at the Nikkei-FT Infectious Disease Conference session, Rahul Dwivedi of #GARDP said:
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
October 13, 2025 at 3:02 AM
GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror.
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
Co-creating an innovative AI platform to advance global health research | Medicines for Malaria Venture
Researchers from around the world collaborate with MMV and deepmirror to adapt machine-learning platform to accelerate drug discovery.
www.mmv.org
October 10, 2025 at 6:17 AM
GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror.
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
@who.int’s latest report on bacterial diagnostics highlights persistent gaps in rapid, affordable tools — especially where the need is greatest.
GARDP’s Teri Roberts contributed as part of the WHO expert group.
🔗 Read more: www.who.int/publications...
GARDP’s Teri Roberts contributed as part of the WHO expert group.
🔗 Read more: www.who.int/publications...
Landscape analysis of commercially available and pipeline in vitro diagnostics for bacterial priority pathogens
This report maps the available and pipeline diagnostics to detect and identify WHO bacterial priority pathogens and to perform phenotypic antimicrobial susceptibility testing (AST) or genotypic testin...
www.who.int
October 9, 2025 at 9:15 AM
@who.int’s latest report on bacterial diagnostics highlights persistent gaps in rapid, affordable tools — especially where the need is greatest.
GARDP’s Teri Roberts contributed as part of the WHO expert group.
🔗 Read more: www.who.int/publications...
GARDP’s Teri Roberts contributed as part of the WHO expert group.
🔗 Read more: www.who.int/publications...
@who.int’s new report shows the antibacterial R&D pipeline is shrinking — just 90 candidates remain in development, with limited innovation against critical pathogens.
Strengthening both discovery and access is key to tackling AMR.
🔗Read the report: www.who.int/publications...
Strengthening both discovery and access is key to tackling AMR.
🔗Read the report: www.who.int/publications...
Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025
The World Health Organization’s (WHO) “2025 Antibacterial agents in clinical and preclinical development: an overview and analysis” report provides a comprehensive evaluation of the global antibacteri...
www.who.int
October 9, 2025 at 7:12 AM
@who.int’s new report shows the antibacterial R&D pipeline is shrinking — just 90 candidates remain in development, with limited innovation against critical pathogens.
Strengthening both discovery and access is key to tackling AMR.
🔗Read the report: www.who.int/publications...
Strengthening both discovery and access is key to tackling AMR.
🔗Read the report: www.who.int/publications...
📝 Call for abstracts is open for #ACC2026!
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
October 8, 2025 at 6:15 AM
📝 Call for abstracts is open for #ACC2026!
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters